QuantRx Biomedical Corporation (QTXB)
USD 0.0
(400.0%)
USD 0.0
(400.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 100.0% |
| 2017 | -10.85 Thousand USD | -51.32% |
| 2016 | -7174.00 USD | 24.56% |
| 2015 | -9509.00 USD | -2203.76% |
| 2014 | 452.00 USD | -91.82% |
| 2013 | 5527.00 USD | -62.88% |
| 2012 | 14.89 Thousand USD | -20.27% |
| 2011 | 18.67 Thousand USD | -98.75% |
| 2010 | 1.49 Million USD | -40.82% |
| 2009 | 2.52 Million USD | 348.53% |
| 2008 | 562.59 Thousand USD | -24.29% |
| 2007 | 743.06 Thousand USD | 712.42% |
| 2006 | 91.46 Thousand USD | 139.74% |
| 2005 | -230.17 Thousand USD | -545.29% |
| 2004 | -35.66 Thousand USD | -180.28% |
| 2003 | 44.42 Thousand USD | 0.0% |
| 2002 | - USD | 100.0% |
| 2001 | -120 Thousand USD | 40.0% |
| 2000 | -200 Thousand USD | 0.0% |
| 1999 | -200 Thousand USD | -150.0% |
| 1998 | -80 Thousand USD | -14.29% |
| 1997 | -70 Thousand USD | -158.33% |
| 1996 | 120 Thousand USD | 1100.0% |
| 1995 | 10 Thousand USD | 0.0% |
| 1994 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 100.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | -10.85 Thousand USD | -51.32% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 FY | -7174.00 USD | 24.56% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q2 | 626.00 USD | 301.28% |
| 2015 FY | -9509.00 USD | -2203.76% |
| 2015 Q4 | - USD | -100.0% |
| 2015 Q1 | 156.00 USD | -5.45% |
| 2015 Q3 | 590.00 USD | -5.75% |
| 2014 Q3 | -66.00 USD | -633.33% |
| 2014 Q4 | 165.00 USD | 350.0% |
| 2014 Q1 | 361.00 USD | -59.75% |
| 2014 Q2 | -9.00 USD | -102.49% |
| 2014 FY | 452.00 USD | -91.82% |
| 2013 Q2 | 787.00 USD | -75.87% |
| 2013 Q3 | 582.00 USD | -26.05% |
| 2013 Q4 | 897.00 USD | 54.12% |
| 2013 Q1 | 3261.00 USD | 39.0% |
| 2013 FY | 5527.00 USD | -62.88% |
| 2012 Q4 | 2346.00 USD | -60.53% |
| 2012 Q2 | 2283.00 USD | -47.12% |
| 2012 Q3 | 5944.00 USD | 160.36% |
| 2012 Q1 | 4317.00 USD | 2.47% |
| 2012 FY | 14.89 Thousand USD | -20.27% |
| 2011 Q4 | 4213.00 USD | 6.5% |
| 2011 FY | 18.67 Thousand USD | -98.75% |
| 2011 Q3 | 3956.00 USD | 121.25% |
| 2011 Q2 | 1788.00 USD | -79.49% |
| 2011 Q1 | 8719.00 USD | 170.19% |
| 2010 FY | 1.49 Million USD | -40.82% |
| 2010 Q3 | 189.87 Thousand USD | -70.38% |
| 2010 Q1 | 659.25 Thousand USD | -46.4% |
| 2010 Q2 | 640.94 Thousand USD | -2.78% |
| 2010 Q4 | 3227.00 USD | -98.3% |
| 2009 Q3 | 963.02 Thousand USD | 458.91% |
| 2009 Q2 | 172.3 Thousand USD | 8.96% |
| 2009 Q4 | 1.22 Million USD | 27.72% |
| 2009 Q1 | 158.13 Thousand USD | 31.85% |
| 2009 FY | 2.52 Million USD | 348.53% |
| 2008 Q2 | 141.53 Thousand USD | 60.4% |
| 2008 Q1 | 88.24 Thousand USD | -95.74% |
| 2008 FY | 562.59 Thousand USD | -24.29% |
| 2008 Q4 | 119.93 Thousand USD | -43.66% |
| 2008 Q3 | 212.88 Thousand USD | 50.41% |
| 2007 Q3 | -244.74 Thousand USD | 70.89% |
| 2007 FY | 743.06 Thousand USD | 712.42% |
| 2007 Q2 | -840.8 Thousand USD | -245.24% |
| 2007 Q4 | 2.07 Million USD | 946.67% |
| 2007 Q1 | -243.54 Thousand USD | -823.21% |
| 2006 Q4 | 33.67 Thousand USD | 121.0% |
| 2006 Q2 | -144.17 Thousand USD | 41.6% |
| 2006 Q1 | -246.86 Thousand USD | -2936.51% |
| 2006 FY | 91.46 Thousand USD | 139.74% |
| 2006 Q3 | -160.37 Thousand USD | -11.24% |
| 2005 Q3 | -133.19 Thousand USD | -47.45% |
| 2005 Q1 | 1480.00 USD | -88.47% |
| 2005 Q4 | -8130.00 USD | 93.9% |
| 2005 FY | -230.17 Thousand USD | -545.29% |
| 2005 Q2 | -90.32 Thousand USD | -6203.24% |
| 2004 Q1 | 27.84 Thousand USD | 0.0% |
| 2004 Q2 | 17.12 Thousand USD | -38.5% |
| 2004 Q3 | 8561.00 USD | -50.0% |
| 2004 Q4 | 12.84 Thousand USD | 49.99% |
| 2004 FY | -35.66 Thousand USD | -180.28% |
| 2003 FY | 44.42 Thousand USD | 0.0% |
| 2002 FY | - USD | 100.0% |
| 2002 Q1 | -10 Thousand USD | 80.0% |
| 2001 Q4 | -50 Thousand USD | -400.0% |
| 2001 FY | -120 Thousand USD | 40.0% |
| 2001 Q3 | -10 Thousand USD | 50.0% |
| 2001 Q2 | -20 Thousand USD | 60.0% |
| 2001 Q1 | -50 Thousand USD | 0.0% |
| 2000 Q4 | -50 Thousand USD | -25.0% |
| 2000 FY | -200 Thousand USD | 0.0% |
| 2000 Q1 | -50 Thousand USD | 16.67% |
| 2000 Q2 | -50 Thousand USD | 0.0% |
| 2000 Q3 | -40 Thousand USD | 20.0% |
| 1999 Q4 | -60 Thousand USD | 14.29% |
| 1999 Q3 | -70 Thousand USD | -75.0% |
| 1999 Q1 | -40 Thousand USD | 42.86% |
| 1999 FY | -200 Thousand USD | -150.0% |
| 1999 Q2 | -40 Thousand USD | 0.0% |
| 1998 Q2 | 60 Thousand USD | 400.0% |
| 1998 Q1 | -20 Thousand USD | 60.0% |
| 1998 Q3 | -50 Thousand USD | -183.33% |
| 1998 Q4 | -70 Thousand USD | -40.0% |
| 1998 FY | -80 Thousand USD | -14.29% |
| 1997 Q4 | -50 Thousand USD | 28.57% |
| 1997 FY | -70 Thousand USD | -158.33% |
| 1997 Q3 | -70 Thousand USD | 68.18% |
| 1997 Q2 | -220 Thousand USD | -100.0% |
| 1997 Q1 | -110 Thousand USD | 0.0% |
| 1996 Q2 | 10 Thousand USD | -90.0% |
| 1996 FY | 120 Thousand USD | 1100.0% |
| 1996 Q4 | - USD | -100.0% |
| 1996 Q3 | 10 Thousand USD | 0.0% |
| 1996 Q1 | 100 Thousand USD | 233.33% |
| 1995 Q3 | -10 Thousand USD | 0.0% |
| 1995 Q4 | 30 Thousand USD | 400.0% |
| 1995 Q2 | -10 Thousand USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | 10 Thousand USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | 100.0% |
| Ansell Limited | 624.8 Million USD | 100.0% |
| Ansell Limited | 624.8 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 113.94 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 135.05 Thousand USD | 100.0% |
| Psykey, Inc. | 415.97 Thousand USD | 100.0% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
| ConvaTec Group Plc | 1.17 Billion USD | 100.0% |
| Encision Inc. | 3.13 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | - USD | NaN% |
| Innovative MedTech Inc. | 794.01 Thousand USD | 100.0% |
| LifePoint, Inc. | -71.35 Thousand USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 100.0% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | 100.0% |
| Remedent, Inc. | 603.24 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | 275.84 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 100.0% |
| SheerVision, Inc. | 2.17 Million USD | 100.0% |
| United Health Products, Inc. | -4857.00 USD | 100.0% |
| Vasamed, Inc. | -69.38 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | 100.0% |
| Yubo International Biotech Limited | 52.65 Thousand USD | 100.0% |